William Hoffman, Director at Inari Medical, Inc. (NARI), sold 40,000 shares at $45.04 ($1.7M) on 2024-06-17, disclosed to the SEC on 2024-06-20.
Scheduled sale ($1.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.31 | 31,600 | $1.4M | 78.6% |
| 2 | $44.16 | 6,175 | $273K | 15.7% |
| 3 | $45.04 | 2,125 | $96K | 5.5% |
| 4 | $45.85 | 100 | $5K | 0.3% |
| Total | $43.54 avg | 40,000 | $1.7M | 100% |
| Filing → |
| NARI | SELL | 2024-11-20 | $5.5M | — | Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-10-18 | $3.6M | — | Filing → |